Author name: Maple Research Labs

MOTS-c research: a 16-aa peptide encoded in mitochondrial 12S rRNA. Folate cycle inhibition, AMPK activation, nuclear translocation. US-stocked, COA-backed.

KPV (α-MSH 11–13) research: NF-κB suppression without MC1R binding, PepT1-mediated uptake, and preclinical colitis models. US-stocked, COA-backed.

GHK-Cu coordination chemistry, matrix remodeling and gene-expression data from the preclinical record — plus what a US lab should verify on a copper peptide COA.

How CJC-1295 and Ipamorelin engage two separate somatotroph receptors, what the preclinical GH literature actually shows, and how US labs verify a blend vial.

Tirzepatide research overview: dual GIP/GLP-1 receptor pharmacology, biased signaling, rodent metabolic models, and what US labs should verify on a COA.

Retatrutide (LY3437943) research overview: GIP/GLP-1/glucagon triple agonism, the glucagon-arm design problem, rodent data, and COA checks for US labs.

TB-500 and thymosin beta-4 in preclinical research: actin sequestration, the PINCH-ILK-Akt complex, migration and repair models. Research use only.

How BPC-157 drives angiogenesis in animal models: VEGFR2 internalization, the Akt-eNOS axis, Egr-1 and granulation. Research use only.

A US-focused review of the BPC-157 preclinical literature: rat tendon and ligament models, VEGFR2 angiogenesis data, the nitric oxide axis, and where the evidence base is genuinely thin.